Health Canada Approves ADCETRIS A for the Treatment of Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma )--Seattle Genetics, Inc.
http://eon.businesswire.com/news/eon/20130201005809/en/Health-Canada-Approves-ADCETRIS%C2%AE-Brentuximab-Vedotin-Treatment
http://eon.businesswire.com/news/eon/20130201005809/en/Health-Canada-Approves-ADCETRIS%C2%AE-Brentuximab-Vedotin-Treatment
No comments:
Post a Comment